TheHamnerInstitutes CEO and leadership

Dr. Charles E. Hamner Jr. is a Chief Executive Officer at Hamner Institutes The and is based in United States.

Melvin (Mel) Andersen, Ph.D. is Senior Program Advisor at ScitoVation. He has almost 50 years experience in toxicology and risk assessment, primarily developing and applying physiologically based pharmacokinetic and biologically based pharmacodynamic (PBPK) models in quantitative safety assessments. He has worked in the federal government, private industry and academia. In 2007, Dr. Andersen co-authored a National Research Council report, “Toxicity Testing in the 21st Century: A Vision and a Strategy,” and now works with clients to apply new alternative methods (NAMs) and toxicity pathway-based approaches outlined in this report to support chemical safety assessments.

Mel works with clients to assess MOAs using time and dose-related changes in gene expression in cells and tissues, suggests approaches to use NAMs in human health risk assessment, and continues his career-long interest in using PK models in safety assessment. Dr. Andersen has received many awards for professional contributions, including the Frank Blood (1982), Achievement (1984), Arnold J. Lehman (2004), and Merit Awards (2016) from the Society of Toxicology and the Mildred Christian Award for career achievements from the Academy of Toxicological Sciences.

He is a certified industrial hygienist, a diplomate of the American Board of Toxicology, and a Fellow of the Academy of Toxicological Sciences. He has a Ph.D. in biochemistry and molecular biology from Cornell University.